MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art

There is a worldwide expansion in percutaneous therapy for valvular heart disease. Rapidly evolving technology and the general increase in life expectancy will support the evolution of new treatment options dedicated to structural heart interventions. Transcatheter aortic valve implantation for seve...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomasz Tokarek, Artur Dziewierz, Dariusz Dudek
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	transcatheter aortic valve replacement valvular heart disease primary mitral regurgitation secondary mitral regurgitation heart failure. Medicine R
Acceso en línea:	https://doaj.org/article/2243ee47667841abb64b9dbb682c4f8e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2243ee47667841abb64b9dbb682c4f8e
record_format	dspace
spelling	oai:doaj.org-article:2243ee47667841abb64b9dbb682c4f8e2021-12-02T17:46:06ZMitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art1734-93381897-429510.5114/aic.2021.107493https://doaj.org/article/2243ee47667841abb64b9dbb682c4f8e2021-07-01T00:00:00Zhttps://www.termedia.pl/MitraClip-for-mitral-valve-regurgitation-and-transcatheter-aortic-valve-implantation-for-severe-aortic-valve-stenosis-state-of-the-art,35,44588,1,1.htmlhttps://doaj.org/toc/1734-9338https://doaj.org/toc/1897-4295There is a worldwide expansion in percutaneous therapy for valvular heart disease. Rapidly evolving technology and the general increase in life expectancy will support the evolution of new treatment options dedicated to structural heart interventions. Transcatheter aortic valve implantation for severe aortic valve stenosis and percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation have been demonstrated as a feasible, innovative alternative for surgical treatment. Despite the inequality in clinical experience, both procedures have encouraging results and now are a part of everyday clinical practice. More importantly, rapid development is expected in the next decades. However, the global coronavirus disease 2019 (COVID-19) pandemic imposed redistribution of healthcare resources. Hospitals were obliged to modify their workflow and limit TAVI and MitraClip procedures to urgent or in highly symptomatic patients. Despite this encumbrance improvement in technology and experience supported by robust evidence from current studies might extend indications for both procedures. The future holds promise for this treatment modality to become the preferred procedure for all patients despite age or risk and reserving surgical treatment for a minority. Thus, we present state-of-the-art and current evidence for both methods assumed to change the paradigm of treatment of valvular heart failure in the future.Tomasz TokarekArtur DziewierzDariusz DudekTermedia Publishing Housearticletranscatheter aortic valve replacement valvular heart disease primary mitral regurgitation secondary mitral regurgitation heart failure.MedicineRENAdvances in Interventional Cardiology, Vol 17, Iss 2, Pp 155-162 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	transcatheter aortic valve replacement valvular heart disease primary mitral regurgitation secondary mitral regurgitation heart failure. Medicine R
spellingShingle	transcatheter aortic valve replacement valvular heart disease primary mitral regurgitation secondary mitral regurgitation heart failure. Medicine R Tomasz Tokarek Artur Dziewierz Dariusz Dudek MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
description	There is a worldwide expansion in percutaneous therapy for valvular heart disease. Rapidly evolving technology and the general increase in life expectancy will support the evolution of new treatment options dedicated to structural heart interventions. Transcatheter aortic valve implantation for severe aortic valve stenosis and percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation have been demonstrated as a feasible, innovative alternative for surgical treatment. Despite the inequality in clinical experience, both procedures have encouraging results and now are a part of everyday clinical practice. More importantly, rapid development is expected in the next decades. However, the global coronavirus disease 2019 (COVID-19) pandemic imposed redistribution of healthcare resources. Hospitals were obliged to modify their workflow and limit TAVI and MitraClip procedures to urgent or in highly symptomatic patients. Despite this encumbrance improvement in technology and experience supported by robust evidence from current studies might extend indications for both procedures. The future holds promise for this treatment modality to become the preferred procedure for all patients despite age or risk and reserving surgical treatment for a minority. Thus, we present state-of-the-art and current evidence for both methods assumed to change the paradigm of treatment of valvular heart failure in the future.
format	article
author	Tomasz Tokarek Artur Dziewierz Dariusz Dudek
author_facet	Tomasz Tokarek Artur Dziewierz Dariusz Dudek
author_sort	Tomasz Tokarek
title	MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
title_short	MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
title_full	MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
title_fullStr	MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
title_full_unstemmed	MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
title_sort	mitraclip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/2243ee47667841abb64b9dbb682c4f8e
work_keys_str_mv	AT tomasztokarek mitraclipformitralvalveregurgitationandtranscatheteraorticvalveimplantationforsevereaorticvalvestenosisstateoftheart AT arturdziewierz mitraclipformitralvalveregurgitationandtranscatheteraorticvalveimplantationforsevereaorticvalvestenosisstateoftheart AT dariuszdudek mitraclipformitralvalveregurgitationandtranscatheteraorticvalveimplantationforsevereaorticvalvestenosisstateoftheart
_version_	1718379516195241984

MitraClip for mitral valve regurgitation and transcatheter aortic valve implantation for severe aortic valve stenosis: state-of-the-art

Ejemplares similares